Anti-cancer activity of two novel heterocyclic compounds through modulation of VEGFR and miR-122 in mice bearing Ehrlich ascites carcinoma
Hazem, Reem M., Mohamed, Anhar A., Ghareb, Nagat, Mehanna, Eman T., Mesbah, Noha M., Abo-Elmatty, Dina M., Elgawish, Mohamed SalehJournal:
European Journal of Pharmacology
DOI:
10.1016/j.ejphar.2020.173747
Date:
November, 2020
Fichier:
PDF, 5.12 MB
2020
File converter
Plus de résultats de recherche
More benefits 
